Today’s guest post is from Dr. Richard Faris, Chief Commercial and Clinical Officer at PANTHERx Rare.
Richard examines key considerations in launching rare disease therapies. He argues that targeted reach, tighter relationships, and data-driven collaboration can improve success for both patients and manufacturers.
To learn more, download PANTHERx Rare’s free guide: From PDUFA to Patient: A Guide to Rare Disease Launch Success.
Read on for Richard’s insights.
Read more »
